Related Experiment Video
Updated: Jun 21, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Pneumocystis jiroveci: epidemiological, pathophysiological and biological update]
1Fédération des laboratoires, Hôpital d'instruction des armées Legouest, Metz Armées. vedy.serge@wanadoo.fr
Pneumocystis jiroveci pneumonia (PJP) remains a significant threat to immunocompromised patients. Advances in molecular biology have improved understanding and diagnosis, necessitating an updated laboratory strategy.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Pneumocystis jiroveci is an opportunistic fungal pathogen.
- It causes severe pneumonia, particularly in immunocompromised individuals.
- High mortality rates persist despite advances in treatment.
Purpose of the Study:
- To synthesize current knowledge on Pneumocystis jiroveci.
- To review molecular biology advancements in its diagnosis.
- To update laboratory diagnosis strategies for Pneumocystis pneumonia.
Main Methods:
- Literature review of molecular biology techniques.
- Analysis of diagnostic methods for Pneumocystis jiroveci.
- Synthesis of epidemiological and pathophysiological data.
Main Results:
- Molecular biology has significantly advanced the understanding of Pneumocystis jiroveci epidemiology and pathophysiology.
- Numerous molecular diagnostic methods have been published.
- Current diagnostic approaches vary widely.
Conclusions:
- An updated laboratory diagnosis strategy is crucial for managing Pneumocystis pneumonia.
- Integrating molecular techniques can improve diagnostic accuracy and patient outcomes.
- Continued research is needed to refine diagnostic protocols.
More Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

